ScholarLens Back to search
2015•Acta Medicinae SinicaRequires access

Comparison of 23G and 25G+ vitrectomy in treating proliferative diabetic retinopathy

Qin Xu-fan

Open publisher page 0 citations

Abstract

Objective:To observe and compare the clinical outcomes of 23 Gand 25G+ vitrectomy for treatment of proliferative diabetic retinopathy(PDR).Methods:104cases of PDR(152eyes)were randomized into the study group and the control group,each 52cases(76eyes).The patients in the study group received 25G+ vitrectomy,and the patients in the control group were treated with 23 G vitrectomy.The therapeutic effects were compared between two groups.Results:1 The average operative time and iatrogenic injury rate in the study group were respectively(48.65±5.16)min and 3.95%,both significantly lower than those in the control group,(56.65±7.54)min and14.47%(P0.05).2 There was no significant difference in postoperative visual improvement rate and anterior chamber inflammation between the two groups(P0.05).Conclusion:Compared with 23 Gvitrectomy,25G+ vitrectomy has better efficacy and safety in the treatment of proliferative diabetic retinopathy.

About this research paper

What this paper is about

Objective:To observe and compare the clinical outcomes of 23 Gand 25G+ vitrectomy for treatment of proliferative diabetic retinopathy(PDR).Methods:104cases of PDR(152eyes)were randomized into the study group and the control group,each 52cases(76eyes).The patients in the study group received 25G+ vitrectomy,and the patients in the control group were treated with 23 G vitrectomy.The therapeutic effects were compared between two groups.Results:1 The average operative time and iatrogenic injury rate in the study group were respectively(48.65±5.16)min and 3.95%,both significantly lower than those in the control group,(56.65±7.54)min and14.47%(P0.05).2 There was no significant difference in postoperative visual improvement rate and anterior chamber inflammation between the two groups(P0.05).Conclusion:Compared with 23 Gvitrectomy,25G+ vitrectomy has better efficacy and safety in the treatment of proliferative diabetic retinopathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe and compare the clinical outcomes of 23 Gand 25G+ vitrectomy for treatment of proliferative diabetic retinopathy(PDR).Methods:104cases of PDR(152eyes)were randomized into the study group and the control group,each 52cases(76eyes).The patients in the study group received 25G+ vitrectomy,and the patients in the control group were treated with 23 G vitrectomy.The therapeutic effects were compared between two groups.Results:1 The average operative time and iatrogenic injury rate in the study group were respectively(48.65±5.16)min and 3.95%,both significantly lower than those in the control group,(56.65±7.54)min and14.47%(P0.05).2 There was no significant difference in postoperative visual improvement rate and anterior chamber inflammation between the two groups(P0.05).Conclusion:Compared with 23 Gvitrectomy,25G+ vitrectomy has better efficacy and safety in the treatment of proliferative diabetic retinopathy.

Key concepts: Vitrectomy, Diabetic retinopathy, Medicine, Significant difference, Ophthalmology, Retinopathy, Diabetes mellitus, Surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparison of 23G and 25G+ vitrectomy in treating proliferative diabetic retinopathy — Research Paper | ScholarLens